An adult client who resides in a long-term care facility is diagnosed with osteoporosis. The client has a history of falls and dementia. Which nursing intervention will best aid in meeting an outcome goal of injury prevention for this client?
A) Using furniture as obstacles to keep the client in the bed
B) Keeping the bed in the lowest position
C) Keeping a nightlight on in the room
D) The use of wrist restraints
Answer: B
Keeping the bed in the lowest position will reduce the incidence of injury should the client attempt to get up. The use of restraints could increase the incidence of injury. Using the furniture as an obstacle could cause injury if the client is able to get up. A nightlight is useful but is not the best means to prevent injury.
You might also like to view...
Organ transplants can occur with which of the following organs?
A) Lung B) Pancreas C) Liver D) All of the above are correct.
A patient has been admitted to the acute care facility to rule out glomerulonephritis. Assessment findings that are supportive of the potential diagnosis include: (Select all that apply.)
a. flank pain. b. hematuria. c. periorbital edema. d. decrease in blood urea nitrogen (BUN) and creatinine. e. hypertension.
The nurse is teaching the client to self-administer insulin. The client is 5 feet tall and weighs 197 pounds. Which does the nurse include in client teaching?
1. Insert the needle into abdominal tissue at 90-degree angle. 2. Include an air space when drawing up the prescribed dose. 3. Aspirate before injecting to ensure needle is not in a vessel. 4. Instruct client to use an insulin syringe with a 1-inch needle.
The client has been ordered treatment with Sinemet. He tells the nurse that he has previously been diagnosed and treated for malignant melanoma. What is the best response from the nurse?
a. "The medication does not have any effect on diseases such as malignant melanoma." b. "The medication is contraindicated when you have had malignant melanoma." c. "The medication will prevent a recurrence of malignant melanoma." d. "The medication may lead to a recurrence of malignant melanoma."